Manufacturing

Patheon, a global provider of pharmaceutical development and manufacturing services, has agreed to acquire an active pharmaceutical ingredients (API) manufacturing facility in Florence,…
Read More...

Neovacs has partnered with 3P Biopharmaceuticals to manufacture interferon alpha (IFNα) cytokine. The collaboration follows the recent acquisition of the technology for the…
Read More...

Sun Pharma has agreed to acquire 85.1% stake in JSC Biosintez, a Russian pharmaceutical firm engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region.…
Read More...

Marinus Pharmaceuticals presented preclinical data showing that the combination of its CNS-selective GABAA modulator ganaxolone and diazepam administered intravenously (IV) produced a…
Read More...

Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor…
Read More...

Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976)…
Read More...

Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions. The…
Read More...

The US Food and Drug Administration (FDA) has accepted for priority review Bristol-Myers Squibb's supplemental biologics license application (sBLA) for Opdivo (nivolumab) in previously…
Read More...

Virtus Pharmaceuticals has filed a lawsuit against the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS), seeking to prevent a monopoly, and…
Read More...

VBL Therapeutics has entered in to a long-term lease contract for a new stand-alone facility in Modiin, Israel. The site will house VBL's local biological drugs manufacturing facility,…
Read More...

Pilgrim Quality Solutions announced the validated release of Smart Solve Out Of Specification Management (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of…
Read More...

Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharp & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development…
Read More...

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its…
Read More...

Pharma and biotech manufacturers benefit from best-in-class pharma MES combined with local implementation support from PAS-X Endorsed Service Partner. Werum IT Solutions, the…
Read More...

GlaxoSmithKline (GSK) has named Emma Walmsley as its new chief executive officer (CEO). Emma will succeed Andrew Witty as GSK CEO, when he retires on 31March 2017. Emma will join the…
Read More...

Horizon Discovery Group has formed new partnerships with both the Centre for Process Innovation (CPI) and the National Institute for Bioprocessing Research and Training (NIBRT) to…
Read More...

Thermo Fisher Scientific has opened a new GMP standard facility in South Korea to address the growing global demand for clinical services. Strategically located in Seoul, the new…
Read More...

Allergan has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries. Allergan has received $33.4 billion in cash and 100.3 million…
Read More...

ExxPharma Therapeutics LLC  and Halo Pharmaceutical have entered into a collaboration agreement to develop and manufacture drug products for customers of Halo and ExxPharma using…
Read More...